Symeres provides clients looking for integrated drug discovery services with access to a trusted network of high-quality European providers under a single simple contractual agreement.
Symeres has a strong European network of centers of excellence to provide integrated drug discovery for our clients.
Central to this is a strategic alliance with Axxam, a world-class provider of in vitro assay development, screening, and compound profiling services based in Milan, Italy. The combined platforms of Symeres, our wholly owned affiliate Admescope, and Axxam provide the core upon which to build gene-to-candidate discovery programs. Program-specific oncology solutions can also be provided through our Oncolines platform, including cancer cell line proliferation assays, residence time determination, combination studies and mechanistic studies. Additionally, partnerships with world-class companies, such as LeadXPro and Proteros, in areas including structural biology & fragment-based screening through biophysics.
A single contract with Symeres allows our clients access to our network, working together as a single project team.
